[1]张艳萍,曹 玉,孙国平.服用阿司匹林对乳腺癌患者生存获益的Meta分析[J].医学信息,2018,31(20):72-77.[doi:10.3969/j.issn.1006-1959.2018.20.021]
　ZHANG Yan-ping,CAO Yu,SUN Guo-ping.Meta Analysis of the Survival Benefit of Patients with Breast Cancer Treated with Aspirin[J].Medical Information,2018,31(20):72-77.[doi:10.3969/j.issn.1006-1959.2018.20.021]
点击复制

服用阿司匹林对乳腺癌患者生存获益的Meta分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年20期
页码:
72-77
栏目:
论著
出版日期:
2018-10-15

文章信息/Info

Title:
Meta Analysis of the Survival Benefit of Patients with Breast Cancer Treated with Aspirin
文章编号:
1006-1959（2018）20-0072-06
作者:
张艳萍; 曹 玉; 孙国平
安徽医科大学第一附属医院全科医学科，安徽 合肥 230022
Author(s):
ZHANG Yan-ping; CAO Yu; SUN Guo-ping
Department of General Medicine,the First Affiliated Hospital of Anhui Medical University,Hefei 230022,Anhui,China
关键词:
乳腺癌; 阿司匹林; 预后; Meta分析
Keywords:
Breast cancer; Aspirin; Prognosis; Meta-analysis
分类号:
R737.9
DOI:
10.3969/j.issn.1006-1959.2018.20.021
文献标志码:
A
摘要:
目的 采用Meta分析探讨服用阿司匹林是否改善乳腺癌患者的预后。方法 检索PubMed、EMBASE、CNKI等中外数据库中关于服用阿司匹林与乳腺癌预后关系的文献，时间截止至2018年3月，提取全因死亡及乳腺癌特异死亡的相关结果进行效应量的合并，对纳入的数据进行敏感性分析、发表偏倚分析等。所有统计分析均采用Stata12.0软件完成。结果 共纳入11篇文献，其中包括9篇队列研究及2篇巢式病例对照研究，共计乳腺癌患者36862例。Meta分析结果显示，诊断前服用阿司匹林的乳腺癌患者与未服用的患者相比，无论是总死亡率（HR=1.06，95%CI=0.78~1.43）还是肿瘤特异死亡率（HR=1.06，95%CI=0.66~1.69）均无显著改善。诊断后服用阿司匹林并不能降低乳腺癌患者的总死亡率（HR=0.84，95%CI=0.64~1.11），但可降低肿瘤特异死亡率（HR=0.73，95%CI=0.55~0.98）。对纳入文献进行敏感性分析，结果显示，诊断后服用阿司匹林并不能降低肿瘤特异死亡率（HR=0.95，95%CI=0.85~1.06）。结论 服用阿司匹林对改善乳腺癌患者的死亡率无显著作用。
Abstract:
Objective To investigate whether taking aspirin improves the prognosis of breast cancer patients by meta-analysis. Methods The literatures on the relationship between aspirin and breast cancer prognosis in PubMed,EMBASE,CNKI and other Chinese and foreign databases were searched.The results of the combination of all-cause death and breast cancer-specific death were combined until March 2018.The data is subjected to sensitivity analysis,publication bias analysis,and the like.All statistical analyses were performed using Stata 12.0 software.Results A total of 11 articles were included,including 9 cohort studies and 2 nested case-control studies,with a total of 36,862 breast cancer patients.Meta analysis showed that there was no significant improvement in total mortality(HR=1.06,95%CI=0.78~1.43)or tumor specific mortality(HR=1.06,95%CI=0.66~1.69)in patients with breast cancer who took aspirin before diagnosis compared with those who did not.Taking aspirin after diagnosis did not reduce the overall mortality of breast cancer patients(HR=0.84,95%CI=0.64~1.11),but reduced tumor-specific mortality(HR=0.73,95%CI=0.55~0.98).Sensitivity analysis of the included literature showed that taking aspirin after diagnosis did not reduce tumor-specific mortality(HR=0.95,95%CI=0.85~1.06). Conclusion Taking aspirin has no significant effect on improving mortality in breast cancer patients.

参考文献/References:

[1]Fan L,Strasser-Weippl K,Li JJ,et al.Breast cancer in China[J].Lancet Oncol,2014,15(7):e279-e289. [2]Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132. [3]Torre LA,Siegel RL,Ward EM,et al.Global cancer incidence and mortality rates and trends-an update[J].Cancer Epidemiol Biomarkers Prev,2016,25(1):16-27. [4]Rothwell PM,Price JF,Fowkes FG,et al.Short-term effects of daily aspirin on cancer incidence,mortality,and non-vascular death:analysis of the time course of risks and benefits in 51 randomised controlled trials[J].Lancet,2012,379(9826):1602-1612. [5]Albini A,DeCensi A,Cavalli F,et al.Cancer Prevention and Interception:A New Era for Chemopreventive Approaches[J].Clin Cancer Res,2016,22(17):4322-4327. [6]Vilar E,Maresso KC,Hawk ET,et al.Aspirin for Cancer Prevention:One Step Closer[J].JAMA Oncol,2016,2(6):770-771. [7]Blair CK,Sweeney C,Anderson KE,et al.NSAID use and survival after breast cancer diagnosis in post-menopausal women[J].Breast Cancer Res Treat,2007,101(2):191-197. [8]Holmes MD,Chen WY,Li L,et al.Aspirin Intake and Survival After Breast Cancer[J].J Clin Oncol,2010,28(9):1467-1472. [9]Fraser DM,Sullivan FM,Thompson AM,et al.Aspirin use and survival after the diagnosis of breast cancer:a population-based cohort study[J].British Journal of Cancer,2014,111(3):623-627. [10]Wang T,Parada H,Mcclain KM,et al.Pre-diagnostic aspirin use and mortality after breast cancer[J].Cancer Causes Control,2018,29(4-5):417-425. [11]Yiannakopoulou EC.Aspirin and NSAIDs for breast cancer chemoprevention[J].Eur J Cancer Prev,2015,24(5):416-421. [12]陈观玲,刘民锋,叶长生.阿司匹林在乳腺癌防治中应用研究进展[J].中华肿瘤防治杂志,2016,23(22):1522-1526. [13]Stang A.Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J].Eur J Epidemiol,2010,25(9):603-605. [14]Wernli KJ,Hampton JM,Trentham-Dietz A,et al.Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors[J].Pharmacoepidemiol Drug Saf,2011,20(2):131-137. [15]Li Y,Brasky TM,Nie J,et al.Use of non-steroidal anti-inflammatory drugs and survival following breast cancer diagnosis[J].Cancer Epidemiol Biomarkers Prev,2012,21(1):239-242. [16]Barron TI,Flahavan EM,Sharp L,et al.Recent prediagnostic aspirin use,lymph node involvement,and 5-Year mortality in women with stage Ⅰ-Ⅲ breast cancer:a nationwide population-based cohort study[J].Cancer Res,2014,74(15):4065-4077. [17]Murray LJ,Cooper JA,Hughes CM,et al.Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival:a nested case-control study in a breast cancer cohort from the UK Clinical Practice Research Datalink[J].Breast Cancer Res,2014,16(2):R34. [18]Holmes MD,Olsson H,Pawitan Y,et al.Aspirin intake and breast cancer survival-a nation-wide study using prospectively recorded data in Sweden[J].BMC Cancer,2014,14(1):391. [19]Barron TI,Murphy LM,Brown C,et al.De Novo Post-Diagnosis Aspirin Use and Mortality in Women with Stage Ⅰ-Ⅲ Breast Cancer[J].Cancer Epidemiol Biomarkers Prev,2015,24(6):898-904. [20]Bradley MC,Black A,Freedman AN,et al.Prediagnostic Aspirin Use and Mortality in Women With Stage Ⅰ to Ⅲ Breast Cancer:A Cohort Study in the Prostate,Lung,Colorectal,and Ovarian Cancer Screening Trial[J].Cancer,2016,122(13):2067-2075. [21]Labelle M,Begum S,Hynes RO,et al.Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis[J].Cancer Cell,2011,20(5):576-590. [22]Cuzick J,Thorat MA,Bosetti C,et al.Estimates of benefits and harms of prophylactic use of aspirin in the general population[J].Ann Oncol,2015,26(1):47-57.

相似文献/References:

[1]张文魁.硝酸甘油联合阿司匹林治疗心绞痛的临床效果观察[J].医学信息,2018,31(02):119.[doi:10.3969/j.issn.1006-1959.2018.02.043]
　ZHANG Wen-kui.Clinical Effect of Nitroglycerin Combined with Aspirin in the Treatment of Angina Pectoris[J].Medical Information,2018,31(20):119.[doi:10.3969/j.issn.1006-1959.2018.02.043]
[2]董 云.SPECT/CT 双时相99mTc- MIBI断层显像 在乳腺癌诊断中的应用[J].医学信息,2018,31(05):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
　DONG Yun.Application of SPECT/CT Dual-phase 99mTc-MIBI Tomography in the Diagnosis of Breast Cancer[J].Medical Information,2018,31(20):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
[3]宇英久,刘 杰.阿司匹林联合硫酸镁治疗妊娠高血压的疗效观察[J].医学信息,2018,31(06):133.[doi:10.3969/j.issn.1006-1959.2018.06.045]
　YU Ying-jiu,LIU Jie.Clinical Observation of Aspirin Combined with Magnesium Sulfate in the Treatment of Pregnancy-induced Hypertension[J].Medical Information,2018,31(20):133.[doi:10.3969/j.issn.1006-1959.2018.06.045]
[4]李建辉,祝旭龙.乳腺癌的治疗管理——把好生活质量关[J].医学信息,2018,31(13):1.[doi:10.3969/j.issn.1006-1959.2018.13.001]
[5]杨玉峰,李 强,曲国红,等.乳腺癌术前巴德枪穿刺检测ER、PR的临床研究[J].医学信息,2018,31(13):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
　YANG Yu-feng,LI Qiang,QU Guo-hong,et al.Clinical Study on Preoperative ER and PR Detection of Bard Gun Puncture in Breast Cancer[J].Medical Information,2018,31(20):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
[6]刘 曼,厉玛倩倩,徐润润,等.延续性护理对乳腺癌术后化疗患者生活质量与 健康知识水平的影响[J].医学信息,2018,31(16):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
　LIU Man,LIMA Qian-qian,XU Run-run,et al.Effect of Continuous Nursing on Quality of Life and Health Knowledge of Postoperative Chemotherapy Patients with Breast Cancer[J].Medical Information,2018,31(20):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
[7]左洪亮.阿司匹林肠溶片治疗缺血性脑血管疾病的临床效果观察[J].医学信息,2018,31(18):118.[doi:10.3969/j.issn.1006-1959.2018.18.037]
　ZUO Hong-liang.Clinical Observation of Aspirin Enteric-coated Tablets in the Treatment of Ischemic Cerebrovascular Disease[J].Medical Information,2018,31(20):118.[doi:10.3969/j.issn.1006-1959.2018.18.037]
[8]钟 磊,谢海燕,林 霖.电化学发光免疫分析技术检测肿瘤标志物在乳腺癌诊断中的应用[J].医学信息,2018,31(20):155.[doi:10.3969/j.issn.1006-1959.2018.20.048]
　ZHONG Lei,XIE Hai-yan,LIN Lin.Application of Electrochemiluminescence Immunoassay for Detection of Tumor Markers in Diagnosis of Breast Cancer[J].Medical Information,2018,31(20):155.[doi:10.3969/j.issn.1006-1959.2018.20.048]
[9]胡平华,黄 勤,李志华.含卡培他滨方案一线或后线治疗晚期乳腺癌的效果对比[J].医学信息,2018,31(22):142.[doi:10.3969/j.issn.1006-1959.2018.22.041]
　HU Ping-hua,HUANG Qin,LI Zhi-hua.Comparison of the Efficacy of Capecitabine Regimen in the Treatment of Advanced Breast Cancer with First-line or Posterior Line Therapy[J].Medical Information,2018,31(20):142.[doi:10.3969/j.issn.1006-1959.2018.22.041]
[10]阙海涛,曹 斌,秦志刚.EGFL7在乳腺癌中的研究进展[J].医学信息,2018,31(23):32.[doi:10.3969/j.issn.1006-1959.2018.23.010]
　QUE Hai-tao,CAO Bin,QIN Zhi-gang.Research Progress of EGFL7 in Breast Cancer[J].Medical Information,2018,31(20):32.[doi:10.3969/j.issn.1006-1959.2018.23.010]

更新日期/Last Update: 2018-11-09